Designed proteins to treat muscular dystrophy – Medical Xpress – Medical Xpress

June 28, 2017 A cross section of a muscle biopsy: Blood vessels (red) between the muscle fibers and laminin-2 (green), which surrounds each muscle fiber. Credit: University of Basel, Biozentrum

The cell scaffolding holds muscle fibers together and protects them from damage. Individuals who suffer from muscular dystrophy often lack essential components in this cell scaffold. As a result, their muscles lack strength and become progressively weaker. The research team of Prof. Markus Regg at the Biozentrum, University of Basel, has now designed two proteins that stabilize the cell scaffolding link it to the muscle fiber and thereby restore muscle structure and function. Their findings are published in the current issue of Science Translational Medicine.

Muscular dystrophy is a term used to describe many different muscular diseases caused by genetic defects. To date, there are no treatments available to stop disease progression. In their study, the scientists led by Prof. Markus Regg have investigated a specific type of muscular dystrophy, called congenital muscular dystrophy. In an animal model, they demonstrated for the first time that two proteins designed by the researchers not only recover muscle force and increase body weight in the sick animals but also significantly prolong survival.

Severe impairments due to congenital muscular dystrophy

Congenital muscular dystrophy is a rare and severe form of a muscular dystrophy that presents at birth or during infancy. "The children born with this disease are also called ?floppy infants? because of the poor muscle tone and weakness," says Judith Reinhard, first author of the study. "The disease becomes more severe with increasing age, as the muscle wasting progresses." Affected children are often unable to walk independently or they lose this ability with age. The respiratory muscles are also affected. The lifespan is often short and many patients die before reaching adulthood.

Defective gene - defective cell scaffolding

This form of muscular dystrophy results from a genetic defect in laminin-2. This protein is a key component of the cell scaffolding and connects it with the inner part of the muscle fiber, ensuring the stability of the tissue. Consequently, as a result of gene defects in laminin-2 the muscles are extremely unstable and even normal use of the muscles leads to muscle injuries, inflammation and finally to the degeneration of muscle fibers. In these diseased muscles, which are unable to produce laminin-2, another laminin takes over. This protein, called laminin-4, however, is only a poor replacement because it is not well integrated into the cell scaffolding.

Proteins anchor cell scaffolding and stabilize muscle fibers

The researchers designed two proteins that allow the integration of laminin-4 and anchor it to the muscle cell. "Using these linkers, we were able to stabilize the muscle fibers," explains Regg. "When animals with a laminin-2 defect express the two linkers, there was a significant improvement in muscle structure and force and an increase in body weight. We were particularly pleased to observe that these animals also had an almost normal lifespan. Some of them even survived their healthy siblings." Furthermore, the scientists examined muscle biopsies of patients with congenital muscular dystrophy. They found very similar structural defects and laminin-4 was also found in place of laminin-2 in the diseased muscle fibers.

"Both of the designed linker proteins may possibly be used in the future as a gene therapy treatment for congenital muscular dystrophy," says Regg. "Our study is a nice example of how the understanding of a disease on the molecular and cellular level results in new therapeutic options. We are now interested in whether these linker proteins also improve muscle function as well as affect survival in advanced stages of congenital muscular dystrophy."

Explore further: New target may slow disease progression in Duchenne muscular dystrophy

More information: J.R. Reinhard el al., "Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aal4649

Duchenne muscular dystrophy is a chronic disease causing severe muscle degeneration that is ultimately fatal. As the disease progresses, muscle precursor cells lose the ability to create new musclar tissue, leading to faster ...

The average healthy man is 54 percent muscle by mass, but people with muscular dystrophy, an incurable, genetic condition, have almost no muscle at terminal stages of the disease. New research from The Rockefeller University ...

A newly discovered mutation in the INPP5K gene, which leads to short stature, muscle weakness, intellectual disability, and cataracts, suggests a new type of congenital muscular dystrophy. The research was published in the ...

A potential way to treat muscular dystrophy directly targets muscle repair instead of the underlying genetic defect that usually leads to the disease.

Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published ...

Cleveland Clinic researchers have uncovered a biological link between gut bacteria metabolism and obesity. The team showed that blocking a specific intestinal microbial pathway can prevent obesity and insulin resistance, ...

The endothelial cells that comprise blood vessels are uniquely responsive to cues from other organs, since their role is to integrate intimately into tissues and provide a means for delivery of oxygen and nutrients and waste ...

Although the basic outlines of human hearing have been known for years - sensory cells in the inner ear turn sound waves into the electrical signals that the brain understands as sound - the molecular details have remained ...

A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings ...

The billion-year-old primordial system by which early life forms protected themselves against viral infection can still be found in human cells, despite the presence of the much more sophisticated and powerful defense system ...

Mucus is important for maintaining healthy lungs. Inhaled particles, including bacteria and viruses, get trapped in mucus and then ciliatiny hair like projections on the surface of the airway cellssweep the mucus out ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See the original post:
Designed proteins to treat muscular dystrophy - Medical Xpress - Medical Xpress